Testing effectiveness (Phase 2)Study completedNCT03452982What this trial is testingSentinel Lymph Node in Early Ovarian CancerWho this might be right forOvarian Cancer Instituto de Investigacion Sanitaria La Fe 20
Not applicableUnknownNCT05153603What this trial is testingOutcomes of First-line Olaparib Mono-maintenance therapy-a Multicenter, Retrospective Study Using Data From Real-world Clinical SettingWho this might be right forOvarian Neoplasms Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 50
Testing effectiveness (Phase 2)Active Not RecruitingNCT01439659What this trial is testingJuice Plus+ and Juice Plus+ Complete in Ovarian CancerWho this might be right forOvarian Cancer M.D. Anderson Cancer Center 75
Early research (Phase 1)Looking for participantsNCT05107674What this trial is testingNX-1607 in Adults With Advanced MalignanciesWho this might be right forOvarian Cancer, EpithelialGastric CancerGastroEsophageal Junction (GEJ) Cancer+11 more Nurix Therapeutics, Inc. 345
Not applicableStudy completedNCT01846520What this trial is testingFamily Caregiver Palliative Care Intervention in Supporting Caregivers of Patients With Stage II-IV Gastrointestinal, Gynecologic, Urologic and Lung CancersWho this might be right forHealthy SubjectLocalized Transitional Cell Cancer of the Renal Pelvis and UreterMetastatic Transitional Cell Cancer of the Renal Pelvis and Ureter+81 more City of Hope Medical Center 200
Not applicableStudy completedNCT06534424What this trial is testingClinical Impact of Enhanced Risk Assessments in Women With a BRCA1/2 Mutation, CARE StudyWho this might be right forBRCA1/2-Associated Hereditary Breast and Ovarian Cancer Syndrome Ohio State University Comprehensive Cancer Center 152
Testing effectiveness (Phase 2)Study completedNCT02431559What this trial is testingPhase 1/2 Study of Motolimod, Doxorubicin, and Durvalumab in Recurrent, Platinum-Resistant Ovarian CancerWho this might be right forOvarian Cancer Ludwig Institute for Cancer Research 53
Early research (Phase 1)Ended earlyNCT04691375What this trial is testingPY314 in Subjects With Advanced Solid TumorsWho this might be right forAdvanced Solid TumorGynecologic CancerBreast Cancer+6 more Ikena Oncology 86
Early research (Phase 1)Study completedNCT03538028What this trial is testingA Safety and Tolerability Study of INCAGN02385 in Select Advanced MalignanciesWho this might be right forCervical CancerMicrosatellite Instability (MSI)-High Endometrial CancerGastric Cancer (Including Stomach and Gastroesophageal Junction [GEJ])+14 more Incyte Biosciences International Sàrl 22
Large-scale testing (Phase 3)Ended earlyNCT00047632What this trial is testingSafety and Efficacy of Interferon Gamma-1b Plus Chemotherapy for Ovarian and Peritoneal CancerWho this might be right forOvarian CarcinomaPeritoneal Carcinoma InterMune 847
Early research (Phase 1)Looking for participantsNCT07489287What this trial is testingGB-5267 for the Treatment Platinum-Resistant Ovarian, Peritoneal, or Fallopian Tube CancerWho this might be right forPlatinum-resistant Ovarian Cancer Roswell Park Cancer Institute 18
Large-scale testing (Phase 3)WithdrawnNCT03806049What this trial is testingTrial Comparing Niraparib-bevacizumab-Dostarlimab and Niraparib-bevacizumab to Standard of Care in Recurrent Ovarian CancerWho this might be right forOvarian Cancer Nordic Society of Gynaecological Oncology - Clinical Trials Unit
Not applicableUnknownNCT00958698What this trial is testingSymptom Management in Patients With Recurrent or Persistent Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal CancerWho this might be right forFallopian Tube CarcinomaPrimary Peritoneal CarcinomaPsychological Impact of Cancer+1 more Gynecologic Oncology Group 485
Testing effectiveness (Phase 2)Active Not RecruitingNCT05554328What this trial is testingTesting the Use of the Combination of Selumetinib and Olaparib or Selumetinib Alone Targeted Treatment for RAS Pathway Mutant Recurrent or Persistent Ovarian and Endometrial Cancers, A ComboMATCH Treatment TrialWho this might be right forRecurrent Endometrial CarcinomaRecurrent Fallopian Tube CarcinomaRecurrent Ovarian Carcinoma+1 more National Cancer Institute (NCI) 165
Not applicableActive Not RecruitingNCT03045965What this trial is testingHysterectomy and OPPortunistic SAlpingectomyWho this might be right forOvarian CancerComplication Göteborg University 4,400
Not applicableEnded earlyNCT00651716What this trial is testingT Cells in Predicting Acute Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell TransplantWho this might be right forBreast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+8 more Vanderbilt-Ingram Cancer Center 150
Large-scale testing (Phase 3)Looking for participantsNCT06817161What this trial is testingBenefit of Transcutaneous Auricular Vagus Nerve Stimulation in Improving Quality of Life in First Line Treatment of Ovarian Cancer:Who this might be right forOvarian CarcinomaFirst Line ChemotherapyDigestive System Disorders Centre Francois Baclesse 116
Testing effectiveness (Phase 2)Ended earlyNCT03302156What this trial is testingPSMA PET and MRI in Gynecological CancersWho this might be right forGynecologic Cancer University of Wisconsin, Madison 15
Early research (Phase 1)Study completedNCT00471432What this trial is testingOGX-011 and Docetaxel in Treating Patients With Metastatic or Locally Recurrent Solid TumorsWho this might be right forBladder CancerBreast CancerKidney Cancer+4 more NCIC Clinical Trials Group 40
Testing effectiveness (Phase 2)Looking for participantsNCT07670312What this trial is testingEvaluation of XYA02 in Patients With Advanced Solid TumorsWho this might be right forMUC1-expressing Advanced, Relapsed and/or Refractory Solid TumorsNon-Small Cell Lung CancerOvarian Cancer+4 more XYone Therapeutics, Inc 190